Humana Inc. (HUM) Shares Sold by Sit Investment Associates Inc.
Sit Investment Associates Inc. lowered its stake in shares of Humana Inc. (NYSE:HUM) by 14.1% during the second quarter, Holdings Channel reports. The fund owned 13,430 shares of the insurance provider’s stock after selling 2,200 shares during the period. Sit Investment Associates Inc.’s holdings in Humana were worth $2,416,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HUM. Daiwa SB Investments Ltd. boosted its position in Humana by 7.5% in the second quarter. Daiwa SB Investments Ltd. now owns 720 shares of the insurance provider’s stock valued at $132,000 after buying an additional 50 shares during the last quarter. Bessemer Group Inc. boosted its stake in shares of Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock worth $183,000 after buying an additional 797 shares in the last quarter. Spark Investment Management LLC acquired a new stake in shares of Humana during the first quarter worth approximately $274,000. Trust Co boosted its stake in shares of Humana by 12.4% in the first quarter. Trust Co now owns 1,720 shares of the insurance provider’s stock worth $315,000 after buying an additional 190 shares in the last quarter. Finally, Checchi Capital Advisers LLC boosted its stake in shares of Humana by 3.1% in the second quarter. Checchi Capital Advisers LLC now owns 2,196 shares of the insurance provider’s stock worth $395,000 after buying an additional 67 shares in the last quarter. 93.24% of the stock is owned by hedge funds and other institutional investors.
Humana Inc. (NYSE:HUM) traded up 0.44% during trading on Monday, reaching $178.52. 1,029,621 shares of the company’s stock traded hands. The firm has a market capitalization of $26.61 billion, a PE ratio of 27.43 and a beta of 0.90. The company has a 50-day moving average price of $176.80 and a 200 day moving average price of $176.07. Humana Inc. has a one year low of $150.00 and a one year high of $191.65.
Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 EPS for the quarter, topping the consensus estimate of $2.23 by $0.07. The company earned $14 billion during the quarter, compared to analyst estimates of $13.59 billion. Humana had a net margin of 1.76% and a return on equity of 11.11%. The firm’s revenue was up 2.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.67 EPS. On average, analysts anticipate that Humana Inc. will post $9.24 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Thursday, October 13th will be issued a $0.29 dividend. This represents a $1.16 annualized dividend and a yield of 0.65%. The ex-dividend date of this dividend is Tuesday, October 11th. Humana’s payout ratio is presently 18.18%.
A number of analysts have commented on HUM shares. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $198.00 target price for the company in a report on Tuesday, October 4th. Credit Suisse Group AG reaffirmed a “hold” rating on shares of Humana in a report on Tuesday, June 28th. Cantor Fitzgerald reaffirmed a “buy” rating on shares of Humana in a report on Saturday, July 9th. Royal Bank Of Canada upped their target price on shares of Humana from $220.00 to $224.00 and gave the company an “outperform” rating in a report on Friday, July 22nd. Finally, Leerink Swann reaffirmed an “outperform” rating on shares of Humana in a report on Tuesday, June 21st. Five analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $201.00.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.